Business · 12/12/1995Updated: 10/18/2026 · 1 min read
FDA Affirms GRAS Status of Glyceryl Palmitostearate
Summary
The FDA is amending its regulations to confirm that glyceryl palmitostearate is generally recognized as safe for use as a formulation aid in tablets, in response to a petition from Gattefosse, S.A.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →